Adjuvant nivolumab monotherapy vs placebo for localized renal cell carcinoma at high risk of relapse after nephrectomy: Results from Part B of the randomized, phase 3 CheckMate 914 trial.

Autor: Motzer, Robert J., Bex, Axel, Russo, Paul, Tomita, Yoshihiko, Cutuli, Hernan, Rojas, Carlos, Gross-Goupil, Marine, Schinzari, Giovanni, Melichar, Bohuslav, Barthelemy, Philippe, Ruiz Garcia, Abraham, Sosman, Jeffrey A., Grimm, Marc-Oliver, Goh, Jeffrey C., Suárez, Cristina, Kollmannsberger, Christian K., Simsek, Burcin, Spiridigliozzi, Julia, Lee, Chung-Wei, Grünwald, Viktor

Publikováno v: Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, pLBA358-LBA358, 6p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial.

Autor: Motzer RJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Bex A; Netherlands Cancer Institute, Amsterdam, the Netherlands.; University College London, London, United Kingdom., Russo P; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY., Tomita Y; Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan., Cutuli HJ; Hospital Sirio Libanés, Buenos Aires, Argentina., Rojas C; Bradford Hill, Santiago, Chile., Gross-Goupil M; Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France., Schinzari G; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Melichar B; Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic., Barthélémy P; Institut de Cancérologie Strasbourg Europe, Strasbourg, France., Ruiz Garcia A; Hospital 1ro de Octubre, Mexico City, Mexico., Sosman J; Northwestern University Medical Center, Chicago, IL., Grimm MO; Jena University Hospital, Jena, Germany., Goh JC; ICON Research, South Brisbane, QLD, Australia., Suarez C; Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Kollmannsberger CK; BC Cancer, Vancouver, BC, Canada., Nair SG; Lehigh Valley Health Network, Allentown, PA., Shuch BM; University of California Los Angeles, Los Angeles, CA., Huang J; Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China., Simsek B; Bristol Myers Squibb, Princeton, NJ., Spiridigliozzi J; Bristol Myers Squibb, Princeton, NJ., Lee CW; Bristol Myers Squibb, Princeton, NJ., van Kooten Losio M; Bristol Myers Squibb, Princeton, NJ., Grünwald V; University Hospital Essen, Essen, Germany.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 20, pp. JCO2400773. Date of Electronic Publication: 2024 Sep 20.